Apolipoprotein B-100 and ApoA-II Kinetics as Determinants of Cellular Cholesterol Efflux-Reference-Cited by-同舟云学术

Apolipoprotein B-100 and ApoA-II Kinetics as Determinants of Cellular Cholesterol Efflux

Published:2012-09-01 Issue:9 Volume:97 Page:E1658-E1666
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Chan Dick C.¹,Hoang Anh²,Barrett P. Hugh R.¹³,Wong Annett T. Y.¹,Nestel Paul J.²,Sviridov Dmitri²,Watts Gerald F.¹

Affiliation:

1. School of Medicine and Pharmacology (D.C.C., P.H.R.B., A.T.Y.W., G.F.W.), University of Western Australia, Royal Perth Hospital, Perth 6847, Western Australia

2. Baker Heart and Diabetes Institute (A.H., P.J.N., D.S.), Melbourne, Victoria 3004, Australia

3. Faculty of Engineering, Computing and Mathematics (P.H.R.B.), University of Western Australia, Crawley 6009, Western Australia

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/97/9/E1658/9044169/jcem1658.pdf

Reference31 articles.

1. New insights into the regulation of HDL metabolism and reverse cholesterol transport.;Lewis;Circ Res,2005

2. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.;Rosenson;Circulation,2012

3. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.;Khera;N Engl J Med,2011

4. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans.;Schwartz;J Lipid Res,2004

5. Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity.;Chan;J Clin Endocrinol Metab,2002

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease;Current Opinion in Endocrinology, Diabetes & Obesity;2024-08-05

2. Does fish oil supplementation increase cholesterol efflux capacity in familial hypercholesterolaemia?;European Journal of Clinical Investigation;2023-06-29

3. Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol‐lowering treatments?;European Journal of Clinical Investigation;2022-03-24

4. Mathematical Models for Cholesterol Metabolism and Transport;Processes;2022-01-13

5. Associations between High-Density Lipoprotein Functionality and Major Adverse Cardiovascular Events in Patients Who Have Undergone Coronary Computed Tomography Angiography;Journal of Clinical Medicine;2021-05-30